Systemic lupus erythematosus with chronic persistent intracranial hypertension: A case report

Lupus. 2024 Mar;33(3):293-297. doi: 10.1177/09612033241230734. Epub 2024 Jan 29.

Abstract

Objective: The aim is to investigate the clinical characteristics of systemic lupus erythematosus with intracranial hypertension.

Methods: The clinical characteristics of one case of systemic lupus erythematosus with chronic persistent intracranial hypertension were analyzed, and related literature was reviewed by searching Medline and Wanfang databases.

Results: Intracranial hypertension in SLE patients may occur at the onset or during the course of the disease. Our patient was diagnosed with IH 3 years after the onset of SLE. Headache and papilledema were the most common symptoms of intracranial hypertension, followed by nausea or vomiting, vision changes, and cerebral palsy. Our patient had a headache and cranial hypertension that lasted for years, but no papilledema was found. Corticosteroid is currently the mainstay of the treatment of IIH in patients with SLE, and immunosuppressive agents, acetazolamide, intravenous mannitol and furosemide are also used. However, our patient did not respond to these treatments and presents the characteristics of chronic persistent intracranial hypertension.

Conclusion: Systemic lupus erythematosus with intracranial hypertension is a rare manifestation of SLE, which is not completely parallel to SLE activity. Headache and papilledema were the most common presenting symptoms. Different from previous reported cases, our patient had poor response to treatments, showing chronic and persistent characteristics.

Keywords: Systemic lupus erythematosus; intracranial hypertension; literature review.

Publication types

  • Case Reports

MeSH terms

  • Acetazolamide / therapeutic use
  • Headache / etiology
  • Humans
  • Intracranial Hypertension* / diagnosis
  • Intracranial Hypertension* / drug therapy
  • Intracranial Hypertension* / etiology
  • Lupus Erythematosus, Systemic* / complications
  • Lupus Erythematosus, Systemic* / diagnosis
  • Lupus Erythematosus, Systemic* / drug therapy
  • Papilledema* / complications
  • Papilledema* / drug therapy

Substances

  • Acetazolamide